Michael Green, Ph.D.


Education/Training


Institution and Location
Degree, if applicable
Year(s)
Field of Study
Oberlin College, Oberlin, OH
B.A.
1979
Psychobiology
Cornell University, Ithaca, NY
Ph.D.
1984
Neuropsychology
University of California, Los Angeles
Postdoctoral
1986
Neuropsychology


A. Positions and Employment

1986–1992 Assistant Research Psychologist, Psychiatry and Biobehavioral Sciences, Neuropsychiatric Institute, University of California, Los Angeles
1991–1997 Research Director, Clinical Research Unit, Camarillo State Hospital, Camarillo CA
1992–1996 Associate Professor in Residence, Psychiatry and Biobehavioral Sciences, Neuropsychiatric Institute, University of California, Los Angeles
1992–Present Health Sciences Specialist, Psychiatry Service, VA Greater Los Angeles Healthcare System, Los Angeles CA
1996-Present Professor In Residence, Psychiatry and Biobehavioral Sciences, Neuropsychiatric Institute, Geffen School of Medicine, University of California, Los Angeles
1998-Present Executive Board Member and Chief of the Treatment Unit, VA VISN 22 Mental Illness Research, Education and Clinical Center (MIRECC), Los Angeles CA
2004-2005 President, Society for Research in Psychopathology


B. Selected peer-reviewed publications (in chronological order).
***From over 130

Green MF. Cognitive remediation in schizophrenia: Is it time yet? (Special Article) American Journal of Psychiatry, 1993;150:178-187.
Green MF, Mintz J, Bowen L, Marshall BD, Kuehnel TG, Hayden JL, Liberman RP. Prediction of haloperidol reduction in treatment refractory schizophrenia by the span of apprehension. American Journal of Psychiatry 1993;150:1415-1416.
Corrigan PW, Wallace CJ, Schade ML, Green MF. Cognitive dysfunctions and psychosocial skill learning in schizophrenia. Behavior Therapy, 1994;25:5-15.
Green MF, Hugdahl K, Mitchell S. Dichotic listening during auditory hallucinations in schizophrenia. American Journal of Psychiatry, 1994;151:357-362.
Green MF, Satz P, Christenson CD. Minor physical anomalies in schizophrenic patients, manic patients, and their siblings. Schizophrenia Bulletin. 1994;20:433-440.
Green MF, Bracha S, Satz P, Christenson CD. Preliminary evidence for an association between minor physical anomalies and second trimester neurodevelopment in schizophrenia. Psychiatry Research, 1994;53:119-127.
Green MF, Nuechterlein KH, Mintz J. Backward masking in schizophrenia and mania: I Specifying a mechanism. Archives of General Psychiatry, 1994;51:939-944.
Green MF, Nuechterlein KH, Mintz J. Backward masking in schizophrenia and mania: II Specifying the visual channels. Archives of General Psychiatry, 1994;51:945-951
Kern RS, Green MF, Goldstein MJ. Can we modify an indicator of vulnerability to schizophrenia? Journal of Abnormal Psychology, 1995;104:385-389.
Green MF. What are the functional consequences of neurocognitive deficits in schizophrenia? (Special Article) American Journal of Psychiatry, 1996;153:321-330.
Green MF, Nuechterlein KH, Breitmeyer B. Backward masking performance in unaffected siblings of schizophrenia patients: Evidence for a vulnerability indicator. Archives of General Psychiatry, 1997;54:465-472.
Green MF, Marshall BD, Wirshing WC, Ames D, Marder SR, McGurk S, Kern RS, Mintz J. Does risperidone improve verbal working memory in treatment-resistant schizophrenia? American Journal of Psychiatry, 1997;154:799-804.
Kee KS, Kern RS, Marshall BD, Green MF. Risperidone versus haloperidol for perception of emotion in treatment-resistant schizophrenia: preliminary findings. Schizophrenia Research, 1998;31:159-165.
Green MF. Schizophrenia from a Neurocognitive Perspective: Probing the Impenetrable Darkness. Boston, Allyn & Bacon; 1998.
Kern RS, Green MF, Marshall BD, Wirshing WC, Wirshing D, McGurk S, Marder SR, Mintz J. Risperidone vs. haloperidol on reaction time, manual dexterity, and motor learning in treatment-resistant schizophrenia patients. Biological Psychiatry, 1998;44:726-732.
Green MF, Nuechterlein KH. Should schizophrenia be treated as a neurocognitive disorder? Schizophrenia Bulletin, 1999;25:309-319.
Green MF, Nuechterlein KH, Breitmeyer B, Mintz J. Backward masking in unmedicated schizophrenic patients in psychotic remission: Suggestive evidence for aberrant cortical oscillations. American Journal of Psychiatry, 1999;156:1367-1373.
Loberg EM, Hugdahl K, Green MF. Hemispheric asymmetry in schizophrenia: A “dual deficits” model. Biological Psychiatry, 1999;45:76-81.
Wirshing DA, Marshall BD, Green MF, Mintz J, Marder SR, Wirshing WC. Risperidone in Treatment Refractory Schizophrenia. American Journal of Psychiatry, 1999;156:1374-1379.
Green MF, Kern RS, Braff DL, Mintz J. Neurcognitive deficits and functional outcome in schizophrenia: Are we measuring the “right stuff”? Schizophrenia Bulletin, 2000;26:119-136.
Green MF, Braff DL. Translating the basic and clinical cognitive neuroscience of schizophrenia to drug development and clinical trials of antipsychotic medications. Biological Psychiatry, 2001;49:374-384.
Green MF. Schizophrenia revealed: From neurons to social interactions. New York: W.W. Norton; 2001.
Wiedl KH, Wienobst J, Schottke HH, Green MF, Nuechterlein KH. Attentional characteristics of schizophrenic patients differing in learning proficiency in the Wisconsin Card Sorting Test. Schizophrenia Bulletin, 2001;27:687-695.
Brekke JS, Kohrt B, Green MF. Neuropsychological functioning as a moderator of the relationship between psychosocial functioning and the subjective experience of self and life in schizophrenia. Schizophrenia Bulletin, 2001;27:697-708,
Green MF, Marder SR, Glynn SM, McGurk SR, Wirshing WC, Wirshing DA, Liberman RP, Mintz J. The neurocognitive effects of low-dose haloperidol: A two-year comparison with risperidone. Biological Psychiatry 2002;51:972-978.
Kern, R.S., Liberman, R.P., Kopelowicz, A., Mintz, J. & Green, M.F. Applications of errorless learning for improving work performance in schizophrenia. American Journal of Psychiatry, 2002;159:1921-1926.
Sergi, M.J., & Green, M.F. Social perception and early visual processing in schizophrenia. Schizophrenia Research, 2003;59, 233-241.
Green, M.F., Nuechterlein, K.H., Breitmeyer, B. Tsuang, J. & Mintz, J. Forward and backward visual masking in schizophrenia: Effects of age. Psychological Medicine, 2003;33:433-442.
Green, M.F., Mintz, J., Salveson, D., Nuechterlein, K.H., Breitmeyer, B., Light, G., & Braff, D.L. Abnormal gamma range activity in schizophrenia: Evidence from visual masking. (2003) Biological Psychiatry, 2003;53:1113-1119.
Kee KS, Green MF, Mintz J, Brekke JS. Is emotional processing a predictor of functional outcome in schizophrenia? Schizophrenia Bulletin, 2003;29:487-497.
Green, M.F., Kern, R.S., and Heaton, R.K. Longitudinal Studies of Cognition and Functional Outcome in Schizophrenia: Implications for MATRICS. Schizophrenia Research. 2004; 72:41-51.
Green, M.F., Glahn, D., Engel, S.A., Nuechterlein, K.H., Sabb, F., Strojwas, M., & Cohen, M.S. Regional brain activity associated with visual backward masking. Journal of Cognitive Neuroscience. 2005; 17(1):13-23.